RxDoctor Payments Data

Joseph Bognet, DO

Family Medicine · Allentown, PANPI 1699752162

Payments from drug & device makers

$38,719in general payments, 2019–2025

Across 1,834 payments — averaging $21.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$6K
  • AbbVie$4K
  • Novo Nordisk$3K
  • Boehringer Ingelheim$3K
  • Lilly USA, LLC$2K
  • Amgen$1K
  • plus $19K from 54 others

What the payments were for

  • Food & beverage$38,21399%
  • Education$5071%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca156$5,967
AbbVie(2 entities)228$3,627
Novo Nordisk123$2,761
Boehringer Ingelheim79$2,627
Lilly USA, LLC167$2,330
Amgen(2 entities)101$1,477
Mannkind Corporation90$1,254
Amarin Pharma, Inc.91$1,136
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC58$1,044
Johnson & Johnson61$1,039
Bayer38$1,012
Paratek Pharmaceuticals, Inc.59$992
Biocryst US Sales Co., LLC40$936
Esperion Therapeutics, Inc.26$847
Sunovion Pharmaceuticals Inc.35$786
Teva Pharmaceuticals USA, Inc.17$759
Astellas Pharma US Inc26$623
Takeda Pharmaceuticals U.S.A., Inc.35$597
CSL Behring26$597
Merck40$576
Kowa Pharmaceuticals America, Inc.39$454
Phathom Pharmaceuticals, Inc.7$435
Antares Pharma, Inc.20$434
Xeris Pharmaceuticals, Inc.28$419
Pfizer23$385
Abbott28$379
Radius Health, Inc.15$344
Axsome Therapeutics, Inc.9$291
Shire North American Group Inc3$270
Exact Sciences11$234
Sanofi-aventis U.S. LLC2$227
Avanir Pharmaceuticals, Inc.12$225
Novartis9$222
Biohaven Pharmaceuticals, Inc.5$195
Idorsia Pharmaceuticals US Inc5$194
Pulmonx Corporation3$175
GSK4$167
Biohaven Pharmaceutical Holding Company Ltd.3$155
Melinta Therapeutics, LLC2$153
Organogenesis Inc.2$150
Lundbeck LLC9$141
Kyowa Kirin, Inc.5$129
Almatica Pharma LLC7$128
Urovant Sciences Inc1$125
Otsuka America Pharmaceutical, Inc.1$125
Sumitomo Pharma America, Inc.7$114
E.r. Squibb & Sons, L.L.C.7$114
OPKO Pharmaceuticals, LLC2$79
Cumberland Pharmaceuticals, Inc.4$79
Ardelyx, Inc.4$77
Seqirus USA Inc4$74
Alfasigma USA, Inc.5$74
Pharming Healthcare, Inc.4$72
Mylan Specialty L.p.3$67
Tolmar, Inc.4$66
VBI Vaccine (delaware) Inc.3$66
Madrigal Pharmaceuticals2$62
Biogen3$59
Phadia US Inc.3$56
Avion Pharmaceuticals4$56

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$38,719 in reported general payments places this provider in the 95th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$70,415
Medicare patients
196
Services billed
719

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban131$87,468
FarxigaDapagliflozin Propanediol41$52,559
OzempicSemaglutide30$36,635
JardianceEmpagliflozin39$33,892
MounjaroTirzepatide30$31,715
TrulicityDulaglutide23$24,631
RexultiBrexpiprazole16$24,259
AbrysvoRsv Vacc, Pref A And Pref B/Pf69$22,128
AfrezzaInsulin Regular, Human14$19,983
RybelsusSemaglutide16$14,387
ShingrixVaricella-Zoster Ge/As01b/Pf64$13,886
XareltoRivaroxaban19$11,946
MyrbetriqMirabegron23$11,032
Gvoke Hypopen 2-PackGlucagon13$8,326
Levothyroxine Sodium556$5,679

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$385$109,595200 claims
Lilly USA, LLCMounjaro, Trulicity$2,330$56,34653 claims
AstraZenecaFarxiga$5,967$52,55941 claims
Novo NordiskOzempic, Rybelsus$2,761$51,02246 claims
Boehringer IngelheimJardiance$2,627$33,89239 claims
Otsuka America Pharmaceutical, Inc.Rexulti$125$24,25916 claims
Mannkind CorporationAfrezza$1,254$19,98314 claims
GSKShingrix$167$13,88664 claims
Johnson & JohnsonXarelto$1,039$11,94619 claims
Astellas Pharma US IncMyrbetriq$623$11,03223 claims
AbbVieCreon, Synthroid$3,627$4,58239 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Allentown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →